Adrian Sulindro, MD
Physical Medicine & Rehabilitation · Burbank, CANPI 1417333485
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,994 of the $10,898 with a category attached, or 73.4%. 28 manufacturers reported payments, led by Medtronic at 32.6% of the total. Reporting peaked in 2023 at $4,285 and has fallen 83.7% since, to $697 in 2025. Among physical medicine & rehabilitation clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 264 payments — averaging $41.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Boston Scientific$3K
- Spinal Simplicity, LLC$1K
- Painteq LLC$876
- SPR Therapeutics, Inc$288
- Nalu Medical, Inc.$282
- plus $2K from 22 others
Across 1 payment — averaging $410.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$410
What the payments were for
- Consulting fees$1251%
- Travel & lodging$2,05019%
- Food & beverage$7,99473%
- Education$7297%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 109 | $3,551 |
| Boston Scientific | 75 | $3,062 |
| Spinal Simplicity, LLC | 10 | $1,163 |
| Painteq LLC | 6 | $876 |
| SPR Therapeutics, Inc | 7 | $288 |
| Nalu Medical, Inc. | 6 | $282 |
| Abbott | 11 | $280 |
| Stimwave Technologies Incorporated | 1 | $189 |
| Nevro Corp. | 2 | $186 |
| Biotronik NRO, Inc. | 9 | $167 |
| Stryker | 3 | $109 |
| Merz Pharmaceuticals, LLC | 1 | $105 |
| Pfizer | 3 | $88 |
| AbbVie(2 entities) | 3 | $71 |
| Vertos Medical, Inc. | 2 | $68 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $55 |
| Electronic Waveform Lab, Inc. | 1 | $49 |
| Bioventus LLC | 1 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Vertex | 1 | $33 |
| Globus Medical | 1 | $32 |
| Si-bone, Inc. | 1 | $26 |
| MML US, Inc. | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $23 |
| Valinor Pharma, LLC | 1 | $22 |
| Xtant Medical Inc | 1 | $20 |
| Curonix LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$992
- Superion Indirect Decompression System$856
- PAINTEQ$689
- WaveWriter Alpha Prime 16$334
- CFNS StimQ Peripheral Nerve StimulatorSystem$189
- SCS FreedonSpinal Cord Stimulator$189
- Senza Spinal Cord Stimulation System$136
- VANTA ADAPTIVESTIM$125
- Nalu Neurostimulation System$125
- INTELLIS ADAPTIVESTIM$118
- XEOMIN$105
- Proclaim Family of SCS IPGs$101
How this compares
$10,898 in reported general payments places this provider in the 95th percentile of 830 physical medicine & rehabilitation providers in California.
See all physical medicine & rehabilitation providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 24 | $16,673 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 781 | $16,486 |
| Duloxetine Hcl | 296 | $7,355 |
| MovantikNaloxegol Oxalate | 19 | $6,353 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 179 | $4,748 |
| Gabapentin | 443 | $3,629 |
| Pregabalin | 140 | $3,106 |
| Morphine Sulfate ErMorphine Sulfate | 67 | $2,243 |
| Tramadol Hcl | 198 | $1,901 |
| Oxycodone Hcl | 108 | $1,872 |
| Lidocaine | 22 | $1,680 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 70 | $1,589 |
| Diclofenac Sodium | 81 | $1,346 |
| Celecoxib | 14 | $1,104 |
| Cyclobenzaprine Hcl | 189 | $1,006 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Burbank
- Ziyad AyyoubParamount$322K
- Pratik GandhiAnaheim$122K
- Mary OatesSanta Maria$115K
- Kevin BarretteSan Francisco$84K
- Steven SampsonLos Angeles$63K
- Jeffrey ChenSan Diego$59K
- Nanette JoyceSacramento$56K
- Amir RahnavardMonterey$49K
- Kyle RyanSan Diego$39K
- Kyle YangLos Angeles$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.